NCT06341777

Brief Summary

Brain injuries may cause the loss of the ability to see portions of the visual field, the so-called visual field defects (VFDs). VFDs significantly impact the survivors' functional recovery and quality of life, with the majority of patients displaying no spontaneous recovery or being left with residual deficits. Among the available therapies for VFDs, the compensatory scanning training is considered the most promising. Yet, current evidence is insufficient to recommend it in clinical practice, and the scientific community has stressed the need of more high-quality research. The present randomized clinical trial in patients with chronic VFDs caused by brain lesions aims at verifying the feasibility and efficacy of a novel telerehabilitation using a multisensory scanning therapy, by measuring its effects on visual functions and daily activities, and by looking for neural indicators of the therapy-induced improvements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

4 years

First QC Date

March 19, 2024

Last Update Submit

March 26, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Change from baseline in Accuracy on the EF Task

    Computerized visual search task. Participants have to search for the target letter "F" surrounded by distractors "E"s. RTs: median search times (seconds) of correct responses.

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups]

  • Change from baseline in Response Times (RTs) on the EF Task

    Computerized visual search task. Participants have to search for the target letter "F" surrounded by distractors "E"s. RTs: median search times (seconds) of correct responses.

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups]

  • Change from baseline in Accuracy on the Triangle Task

    Computerized visual search task. Participants have to report the number of triangles (targets) surrounded by square distractors. Accuracy: the proportion of correct responses (range 0-1)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in RTs on the Triangle Task

    Computerized visual search task. Participants have to report the number of triangles (targets) surrounded by square distractors. RTs: median search times (seconds) of correct responses.

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in RTs on the Numbers Task

    Computerized visual search task. Participants have to point to numbers (1 to 15) in ascending order. RTs: median search times (seconds).

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in omissions on the Bell Test (only children)

    Participants have to cross out Bells (targets) among different distractors. Omissions: number of omitted targets.

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in RTs on the Bell Test (only children)

    Participants have to cross out Bells (targets) among different distractors. RTs: median search times (seconds).

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in Accuracy on the Small Faces Test (only children)

    Participants have to cross out targets among distractors. Accuracy: the number of correct responses

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in RTs on the Small Faces Test (only children)

    Participants have to cross out targets among distractors; RTs: median search times (seconds).

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

Secondary Outcomes (14)

  • Change from baseline in Daily Living Dependent on Vision Questionnaire (total score)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in the Reading test (reading time)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in the Hamilton Anxiety Scale (total score; only adults)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in the Beck's Depression Inventory (BDI; total score; only adults)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • Change from baseline in the Multidimensional Anxiety Scale for Children (MASC; total score; only children)

    At baseline (at the beginning of the treatment), at the end of the treatment, at 1- and 6-month follow-ups

  • +9 more secondary outcomes

Study Arms (3)

Immediate Intervention (IM group)

EXPERIMENTAL

HVDFs patients who start the audio-visual telerehabilitation immediately

Behavioral: Audio-visual training (AVT) telerehabilitation

WaitList Delayed Intervention (WL group)

EXPERIMENTAL

HVDFs patients waiting 1 month before receiving the audio-visual telerehabilitation.

Behavioral: Audio-visual training (AVT) telerehabilitation

Healthy Participants

NO INTERVENTION

A group of 12 healthy participants is recruited for comparisons of MRI-based connectivity metrics

Interventions

Participants are trained at home, with remote supervision, for 3 weeks (5 days/week, 2 hours/day) using an audio-visual device suitable for telerehabilitation (AVDESK, Linari Medical). Specifically, visual stimuli (LEDs) appear on a semicircular panel, either alone or paired with an acoustic cues, at different eccentricities. Stimuli to the blind visual field (70%) and intact visual field (30%) are presented in random sequence. Patients are trained to scan the visual field by shifting their gaze (from the central fixation point) towards the visual target (with or without sounds), without head movements, and to report its presence by pressing the response key.

Immediate Intervention (IM group)WaitList Delayed Intervention (WL group)

Eligibility Criteria

Age6 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Acquired homonymous visual field defect (HVFDs) due stroke, traumatic brain injury, tumor, surgery for epilepsy in a chronic stage of illness (time from the lesion \>6 months)
  • Normal hearing
  • Normal or corrected-to-normal visual acuity

You may not qualify if:

  • cognitive decline (adults)
  • intellectual disability (children)
  • major neurological or psychiatric disease
  • being enrolled in another therapy for HVFDs
  • not being enrolled in another VFDs therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Auxologico Italiano IRCCS

Milan, Lombardy, 20122, Italy

Location

Related Publications (1)

  • Bolognini N, Diana L, Rossetti A, Melzi L, Basso G, Manzo V, Cruz-Sanabria F, Cammarata G, Cernigliaro F, Bianchi Marzoli S, Tinelli F, Fiori S, Casati C. Telerehabilitation for visual field defects with a multisensory training: a feasibility study. J Neuroeng Rehabil. 2025 Feb 24;22(1):34. doi: 10.1186/s12984-025-01573-4.

MeSH Terms

Conditions

HemianopsiaBrain Injuries

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Vision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesBlindnessEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2024

First Posted

April 2, 2024

Study Start

January 1, 2020

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

April 2, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Anonymized individual data will be made available on zenodo.com

Time Frame
Data will become available right before the first submission of the first paper.
Access Criteria
Upon request to l.diana@auxologico.it

Locations